 | |
| Discipline | Cardiology, cardiovascular biology |
|---|---|
| Language | English |
| Edited by | Alan Daugherty |
| Publication details | |
Former name(s) | Arteriosclerosis; Arteriosclerosis and Thrombosis |
| History | 1981–present |
| Publisher | Lippincott Williams & Wilkins on behalf of the American Heart Association (United States) |
| Frequency | Monthly |
| Hybrid | |
| 10.514 (2021) | |
| Standard abbreviations | |
| ISO 4 | Arterioscler. Thromb. Vasc. Biol. |
| Indexing | |
| CODEN | ATVBFA |
| ISSN | 1079-5642 (print) 1524-4636 (web) |
| LCCN | 95644718 |
| OCLC no. | 31441121 |
| Links | |
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.
The journal was established in 1981 as Arteriosclerosis (ISSN 0276-5047), which was published bimonthly. From 1991 to 1994 it was published monthly under the title Arteriosclerosis and Thrombosis: A Journal of Vascular Biology (ISSN 1049-8834).[1]
According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311,[2] ranking it 8th in the category "Hematology"[2] and 5th in the category "Peripheral Vascular Disease".[2] Alan Daugherty has been the editor-in-chief since 2012.[3]